Literature DB >> 18523712

Ancient origin of the Parkinson disease gene LRRK2.

Ignacio Marín1.   

Abstract

Dominant mutations in the LRRK2 gene, a member of the Roco family, cause both familial and sporadic Parkinson disease. LRRK genes had so far been detected only in bilaterian animals. In deuterostomes, including humans, two LRRK genes (LRRK1 and LRRK2) exist, while in protostomes a single LRRK gene has been found. In this study, I combine structural and phylogenetic analyses to show that the cnidarian Nematostella vectensis has four LRRK genes. One of them is a bona fide orthologue of the human LRRK2 gene, demonstrating that this gene has an ancient origin. Two others are, respectively, orthologues of the deuterostome LRRK1 and the protostome LRRK genes. The fourth gene is probably cnidarian-specific. This precise characterization of the early evolution of LRRK genes in animals has important implications, because it indicates that the Drosophila and Caenorhabditis LRRK genes, which are studied to gain an understanding of LRRK2 function, are not true orthologues of the human Parkinson disease gene. Novel functional insights are also gained by comparison of the structures of LRRK2 genes in distantly related species.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18523712     DOI: 10.1007/s00239-008-9122-4

Source DB:  PubMed          Journal:  J Mol Evol        ISSN: 0022-2844            Impact factor:   2.395


  34 in total

1.  The familial Parkinsonism gene LRRK2 regulates neurite process morphology.

Authors:  David MacLeod; Julia Dowman; Rachel Hammond; Thomas Leete; Keiichi Inoue; Asa Abeliovich
Journal:  Neuron       Date:  2006-11-22       Impact factor: 17.173

2.  Type and frequency of mutations in the LRRK2 gene in familial and sporadic Parkinson's disease*.

Authors:  Daniela Berg; Katherine J Schweitzer; Petra Leitner; Alexander Zimprich; Peter Lichtner; Petra Belcredi; Theresa Brüssel; Claudia Schulte; Sylvia Maass; Thomas Nägele; Zbigniew K Wszolek; Thomas Gasser
Journal:  Brain       Date:  2005-12       Impact factor: 13.501

3.  Comparative genomics and protein domain graph analyses link ubiquitination and RNA metabolism.

Authors:  J Ignasi Lucas; Vicente Arnau; Ignacio Marín
Journal:  J Mol Biol       Date:  2006-01-09       Impact factor: 5.469

4.  The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools.

Authors:  J D Thompson; T J Gibson; F Plewniak; F Jeanmougin; D G Higgins
Journal:  Nucleic Acids Res       Date:  1997-12-15       Impact factor: 16.971

Review 5.  LRRK2: a common pathway for parkinsonism, pathogenesis and prevention?

Authors:  Julie P Taylor; Ignacio F Mata; Matt J Farrer
Journal:  Trends Mol Med       Date:  2006-01-10       Impact factor: 11.951

Review 6.  LRRK2 in Parkinson's disease: protein domains and functional insights.

Authors:  Ignacio F Mata; William J Wedemeyer; Matthew J Farrer; Julie P Taylor; Kathleen A Gallo
Journal:  Trends Neurosci       Date:  2006-04-17       Impact factor: 13.837

7.  LRRK2 mutation analysis in Parkinson disease families with evidence of linkage to PARK8.

Authors:  W C Nichols; V E Elsaesser; N Pankratz; M W Pauciulo; D K Marek; C A Halter; A Rudolph; C W Shults; T Foroud
Journal:  Neurology       Date:  2007-09-05       Impact factor: 9.910

8.  Corticobasal syndrome and primary progressive aphasia as manifestations of LRRK2 gene mutations.

Authors:  A S Chen-Plotkin; W Yuan; C Anderson; E McCarty Wood; H I Hurtig; C M Clark; B L Miller; V M-Y Lee; J Q Trojanowski; M Grossman; V M Van Deerlin
Journal:  Neurology       Date:  2007-10-03       Impact factor: 9.910

9.  The Parkinson's disease-associated protein, leucine-rich repeat kinase 2 (LRRK2), is an authentic GTPase that stimulates kinase activity.

Authors:  Luxuan Guo; Payal N Gandhi; Wen Wang; Robert B Petersen; Amy L Wilson-Delfosse; Shu G Chen
Journal:  Exp Cell Res       Date:  2007-07-19       Impact factor: 3.905

10.  Leucine-rich repeat kinase 2 associates with lipid rafts.

Authors:  Taku Hatano; Shin-Ichiro Kubo; Satoshi Imai; Masahiro Maeda; Kiyoshi Ishikawa; Yoshikuni Mizuno; Nobutaka Hattori
Journal:  Hum Mol Genet       Date:  2007-03-06       Impact factor: 6.150

View more
  31 in total

1.  Leucine-rich repeat kinase 2 deficiency is protective in rhabdomyolysis-induced kidney injury.

Authors:  Ravindra Boddu; Travis D Hull; Subhashini Bolisetty; Xianzhen Hu; Mark S Moehle; João Paulo Lima Daher; Ahmed Ibrahim Kamal; Reny Joseph; James F George; Anupam Agarwal; Lisa M Curtis; Andrew B West
Journal:  Hum Mol Genet       Date:  2015-04-22       Impact factor: 6.150

2.  RBR ubiquitin ligases: Diversification and streamlining in animal lineages.

Authors:  Ignacio Marín
Journal:  J Mol Evol       Date:  2009-06-13       Impact factor: 2.395

Review 3.  Role of LRRK2 kinase dysfunction in Parkinson disease.

Authors:  Azad Kumar; Mark R Cookson
Journal:  Expert Rev Mol Med       Date:  2011-06-13       Impact factor: 5.600

4.  Characterization of the Roco protein family in Dictyostelium discoideum.

Authors:  Wouter N van Egmond; Peter J M van Haastert
Journal:  Eukaryot Cell       Date:  2010-03-26

Review 5.  CRISPR System: A High-throughput Toolbox for Research and Treatment of Parkinson's Disease.

Authors:  Fatemeh Safari; Gholamreza Hatam; Abbas Behzad Behbahani; Vahid Rezaei; Mazyar Barekati-Mowahed; Peyman Petramfar; Farzaneh Khademi
Journal:  Cell Mol Neurobiol       Date:  2019-11-26       Impact factor: 5.046

6.  Structural and functional in silico analysis of LRRK2 missense substitutions.

Authors:  Fernando Cardona; Marta Tormos-Pérez; Jordi Pérez-Tur
Journal:  Mol Biol Rep       Date:  2014-02-02       Impact factor: 2.316

7.  Deletion of the WD40 domain of LRRK2 in Zebrafish causes Parkinsonism-like loss of neurons and locomotive defect.

Authors:  Donglai Sheng; Dianbo Qu; Ken Hon Hung Kwok; Seok Shin Ng; Adrian Yin Ming Lim; Sharon Siqi Aw; Charlie Wah Heng Lee; Wing Kin Sung; Eng King Tan; Thomas Lufkin; Suresh Jesuthasan; Mathavan Sinnakaruppan; Jianjun Liu
Journal:  PLoS Genet       Date:  2010-04-22       Impact factor: 5.917

8.  The therapeutic potential of LRRK2 and alpha-synuclein in Parkinson's disease.

Authors:  Saurabh Sen; Andrew B West
Journal:  Antioxid Redox Signal       Date:  2009-09       Impact factor: 8.401

9.  Update on the functional biology of Lrrk2.

Authors:  Heather Melrose
Journal:  Future Neurol       Date:  2008

10.  The WD40 domain is required for LRRK2 neurotoxicity.

Authors:  Nathan D Jorgensen; Yong Peng; Cherry C-Y Ho; Hardy J Rideout; Donald Petrey; Peng Liu; William T Dauer
Journal:  PLoS One       Date:  2009-12-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.